Pegcetacoplan vs Trastuzumab
## Pegcetacoplan vs Trastuzumab: Overview
This comparison examines the pharmacological differences between **Pegcetacoplan** and **Trastuzumab**.
## Mechanism of Action
**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
## Pharmacokinetics
**Half-life**: Pegcetacoplan — N/A; Trastuzumab — 28 days.
## Chemical Properties
**Type**: Pegcetacoplan — Protein; Trastuzumab — Antibody.